|
CSNK2A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.572500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.311800E-02 |
| Normal-vs-Stage2 |
1.718990E-01 |
| Normal-vs-Stage3 |
6.722700E-03 |
| Normal-vs-Stage4 |
2.193600E-01 |
| Stage1-vs-Stage2 |
5.645400E-01 |
| Stage1-vs-Stage3 |
3.242100E-02 |
| Stage1-vs-Stage4 |
5.333400E-01 |
| Stage2-vs-Stage3 |
1.778360E-01 |
| Stage2-vs-Stage4 |
8.666200E-01 |
| Stage3-vs-Stage4 |
3.578600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.570700E-04 |
| Normal-vs-AfricanAmerican |
6.246400E-02 |
| Normal-vs-Asian |
8.773400E-01 |
| Caucasian-vs-AfricanAmerican |
6.956200E-01 |
| Caucasian-vs-Asian |
5.714000E-01 |
| AfricanAmerican-vs-Asian |
6.457000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.471900E-02 |
| Normal-vs-Female |
3.31779999995785E-06 |
| Male-vs-Female |
9.606000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.132970E-01 |
| Normal-vs-Extreme_Weight |
6.908800E-01 |
| Normal-vs-Obese |
6.385000E-04 |
| Normal-vs-Extreme_Obese |
8.260200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.039600E-01 |
| Normal_Weight-vs-Obese |
3.180800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.832000E-01 |
| Extreme_Weight-vs-Obese |
6.656100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.267000E-01 |
| Obese-vs-Extreme_Obese |
2.224800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.299810E-02 |
| Normal-vs-Age(41-60Yrs) |
1.197080E-04 |
| Normal-vs-Age(61-80Yrs) |
1.270990E-01 |
| Normal-vs-Age(81-100Yrs) |
3.730200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.626760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.839000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.002700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.839690E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.096600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.521600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.024300E-02 |
| Normal-VS-Type2 PRCC |
1.425960E-01 |
| Normal-VS-KIRP CIMP |
8.902400E-03 |
| Normal-VS-Unclassified PRCC |
1.777760E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.009400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.937300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.206000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.516200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.476200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.447000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.038000E-01 |
| Normal-vs-N1 |
9.205000E-04 |
| Normal-vs-N2 |
4.421800E-01 |
| N0-vs-N1 |
7.436700E-03 |
| N0-vs-N2 |
6.389400E-01 |
| N1-vs-N2 |
3.971800E-01 |
|
|
